Immunome, Inc. Share Price
NASDAQ: IMNMHealthcare
Live Immunome, Inc. Share Price Chart
O H L
Immunome, Inc. Performance Overview
Days Range
▼
$23.43Low
$24.04High
Markets Today
| Previous Close | $23.93 |
|---|---|
| Open | $24.04 |
| Volume | 132,459 |
| Day's Range | $23.43 - $24.04 |
| 52W Range | $8.93 - $30.06 |
| Market Cap | $2.66 B |
Historical Performance
| 1M Returns | -13.17 |
|---|---|
| 3M Returns | +27.69 |
| 6M Returns | +16.05 |
| 1Y Returns | +142.94 |
| 5Y Returns | -3.00 |
| 10Y Returns | NA |
Immunome, Inc. Fundamentals
| Market Cap | $2.66 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $6.94 M |
| ROE TTM | -0.52 |
| EPS TTM | $-2.51 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.07 |
| EBITDA | $-221.65 M |
| Profit Margin | -3059.99 |
| Market Cap | $2.66 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $6.94 M |
| ROE TTM | -0.52 |
| EPS TTM | $-2.51 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.07 |
| EBITDA | $-221.65 M |
| Profit Margin | -3059.99 |
Immunome, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.93 M | $4.01 M | $0 | $0 | $0 | $0 |
| Gross Profit + | $2.93 M | $4.01 M | $0 | $0 | $0 | $0 |
| Operating Income | -$44.64 M | -$46.48 M | -$60.14 M | -$72.86 M | -$59.33 M | -$78.14 M |
| EBITDA | -$44.02 M | -$45.84 M | -$59.55 M | -$72.23 M | -$58.73 M | -$77.18 M |
| Interest Expense | $0 | $0 | $2.68 M | $2.96 M | $0 | $0 |
| Depreciation | $611.00 K | $637.00 K | $589.00 K | $629.00 K | $603.00 K | $957.00 K |
| Income Before Tax | -$41.70 M | -$43.40 M | -$57.46 M | -$69.90 M | -$53.84 M | -$73.13 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$41.70 M | -$43.40 M | -$57.46 M | -$69.90 M | -$53.84 M | -$73.13 M |
| Net Profit Margin | -1425.15% | -1080.87% | - | - | - | - |
Immunome, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $9.00 K | $9.00 K | $9.00 K | $11.00 K | $11.00 K | $11.00 K |
| Reserve & Surplus | -$557.41 M | -$600.83 M | -$658.26 M | -$728.16 M | -$782.00 M | -$855.46 M |
| Non-Current Liabilities | $4.77 M | $4.14 M | $4.01 M | $3.85 M | $3.69 M | $4.59 M |
| Current Liabilities | $30.80 M | $22.88 M | $31.45 M | $44.99 M | $27.41 M | $35.71 M |
| Total Liabilities | $35.57 M | $27.02 M | $35.46 M | $48.84 M | $31.11 M | $40.30 M |
| Fixed Assets | $10.95 M | $11.03 M | $11.56 M | $14.64 M | $17.08 M | $17.36 M |
| Current Assets | $323.13 M | $277.43 M | $279.92 M | $660.78 M | $594.31 M | $538.45 M |
| Total Assets | $342.69 M | $296.29 M | $299.38 M | $683.19 M | $619.79 M | $565.38 M |
Immunome, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$41.64 M | -$43.40 M | -$57.46 M | -$69.90 M | -$53.84 M | -$73.13 M |
| Operating Cash Flow | -$53.05 M | -$49.40 M | -$40.51 M | -$47.95 M | -$58.64 M | -$61.69 M |
| Investing Cash Flow | $5.09 M | -$64.17 M | $123.88 M | -$4.00 M | -$12.02 M | -$304.35 M |
| Financing Cash Flow | $162.23 M | -$55.00 K | $45.39 M | $432.80 M | -$135.00 K | $1.06 M |
| Change in Cash | $114.26 M | -$113.63 M | $128.76 M | $380.84 M | -$70.79 M | -$364.99 M |
Immunome, Inc. Return Calculator
The Immunome, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$9,481
Invested Amount$10,000
Est. Returns$-519
About Immunome, Inc.
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Popular Stocks
FAQs
What is the share price of Immunome, Inc. today?
Immunome, Inc. (IMNM) share price as of September 18, 2026 is $23.39. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Immunome, Inc.?
Yes, Indian Investors can invest in the Immunome, Inc. (IMNM) Share by opening an international trading account with Angel One.
How can I purchase Immunome, Inc. shares in India?
Purchasing Immunome, Inc. (IMNM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Immunome, Inc. (IMNM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Immunome, Inc.?
Yes, you can purchase fractional shares of Immunome, Inc. (IMNM) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Immunome, Inc.?
The market capitalization of Immunome, Inc. on September 18, 2026, is $2.66 B.
In which sector Immunome, Inc. belongs?
Immunome, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Immunome, Inc. stocks?
In order to invest in Immunome, Inc. (IMNM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
